From: How COVID-19 pandemic changed our management strategies for amyotrophic lateral sclerosis (ALS) patients: Egyptian study
Mean age (years) ± SD
49.4 ± 11.8
Limb onset
31/43 (72.1%)
Bulbar onset
12/43 (27.9%)
Mean ALSFRS-R (Pre-Televisit) ± SD
31.7 ± 6.9
Mean ALSFRS-R (Televisit) ± SD
29.9 ± 6.5